| Chaitanya Vemulapalli, MD | |
|
1096 S Belsay Rd, Ste J, Burton, MI 48509-1948 | |
| (810) 715-0803 | |
| (810) 715-0824 |
| Full Name | Chaitanya Vemulapalli |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 20 Years |
| Location | 1096 S Belsay Rd, Burton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700166733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301098452 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Medical Center | Warner robins, GA | Hospital |
| Coffee Regional Medical Center, Inc | Douglas, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Universal Radiology Consultants Pc | 2769485655 | 10 |
News Archive
Cancer cases in adolescents and young adults have risen by 30% during the last four decades, with kidney cancer rising at the greatest rate, according to researchers at Penn State College of Medicine.
Chronic conditions including obesity, cardiovascular disease, and cancer often begin with early, subtle changes in cellular metabolism.
Hygafem, the Georgia-based premier provider of full-service hygiene technologies, announced today that the company has changed its name to WellBeing. WellBeing is introducing a new and evolving touch-free hygiene and organizational wellness platform that communicates the company's ongoing commitment to "green" hygiene services, excellence and innovation.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Developing new drugs is a highly costly and time-consuming process. Of 20 candidates, 19 are normally rejected because they don't work or have unwanted side effects. Now a research team led by Professor Lars Baltzer at Uppsala University has produced a tiny molecular "binder" that has the potential to change this landscape radically.
› Verified 3 days ago
| Entity Name | Universal Radiology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689606188 PECOS PAC ID: 2769485655 Enrollment ID: O20060815000151 |
News Archive
Cancer cases in adolescents and young adults have risen by 30% during the last four decades, with kidney cancer rising at the greatest rate, according to researchers at Penn State College of Medicine.
Chronic conditions including obesity, cardiovascular disease, and cancer often begin with early, subtle changes in cellular metabolism.
Hygafem, the Georgia-based premier provider of full-service hygiene technologies, announced today that the company has changed its name to WellBeing. WellBeing is introducing a new and evolving touch-free hygiene and organizational wellness platform that communicates the company's ongoing commitment to "green" hygiene services, excellence and innovation.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Developing new drugs is a highly costly and time-consuming process. Of 20 candidates, 19 are normally rejected because they don't work or have unwanted side effects. Now a research team led by Professor Lars Baltzer at Uppsala University has produced a tiny molecular "binder" that has the potential to change this landscape radically.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chaitanya Vemulapalli, MD 3495 S Center Rd, Burton, MI 48519-1455 Ph: (810) 424-2011 | Chaitanya Vemulapalli, MD 1096 S Belsay Rd, Ste J, Burton, MI 48509-1948 Ph: (810) 715-0803 |
News Archive
Cancer cases in adolescents and young adults have risen by 30% during the last four decades, with kidney cancer rising at the greatest rate, according to researchers at Penn State College of Medicine.
Chronic conditions including obesity, cardiovascular disease, and cancer often begin with early, subtle changes in cellular metabolism.
Hygafem, the Georgia-based premier provider of full-service hygiene technologies, announced today that the company has changed its name to WellBeing. WellBeing is introducing a new and evolving touch-free hygiene and organizational wellness platform that communicates the company's ongoing commitment to "green" hygiene services, excellence and innovation.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Developing new drugs is a highly costly and time-consuming process. Of 20 candidates, 19 are normally rejected because they don't work or have unwanted side effects. Now a research team led by Professor Lars Baltzer at Uppsala University has produced a tiny molecular "binder" that has the potential to change this landscape radically.
› Verified 3 days ago
Dr. Kyung-woong Moon, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1096 S Belsay Rd, Suite J, Burton, MI 48509 Phone: 810-715-0803 Fax: 810-715-0824 |